RepRegen

About:

RepRegen develops a hard tissue repair and regeneration platform to be used by orthopedic product manufacturers and surgeons. 

Website: http://www.repregen.com

Twitter/X: repregen

Top Investors: Imperial Innovations, Longbow Capital

Description:

A spin-out from Imperial Innovations plc and headquartered within the Imperial College Incubator, RepRegen is poised to commercialize the initial product of its hard tissue repair and regeneration platform: StronBoneâ„¢ Bone Graft Substitute. The Company's hard tissue platform is based on 'smart' bioceramics designed to be used, initially, by orthopedic product manufacturers and surgeons. A major RepRegen materials science innovation is the use of Strontium, boosting the performance of the bioceramics.